Projects

01/2019-12/2022

I-DireCT

The mission of I-DireCT is to provide training and carry out breakthrough research on the rapidly expanding and high impact field of cancer immunotherapy in a carefully integrated academic and inter-sectoral programme.

Partners:
The University Medical Center Groningen (UMCG) | University Hospital Wuerzburg (UKW) | InoCure s.r.o. | KAHR Medical

Financial support: 
This project has received funding from the Research and Innovation Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie Action (grant agreement No. 813871).

03/2018-02/2021

Immunoplex: Screening of auto-immune diseases by multiplex Whispering Gallery Mode (WGM) sensors

Surflay's WhisperSense technology is used and further developed for a reliable and cost-efficient screening of auto-immune diseases in samples.

Partners:
Diarect AG | Scienion AG

Financial support: 
Bundesministerium für Bildung und Forschung (BMBF) (grant agreement No. 031 B498 A)